1. Delayed neurological improvement after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry

   • Dapeng Sun
   • Raynald -
   • Zhongrong Miao

   OriginalPaper 27 October 2022 Pages: 1 - 8

   

2. Platelet storage: Progress so far

   • Vani Rajashekaraiah
   • Magdaline Christina Rajanand

   ReviewPaper 31 October 2022 Pages: 9 - 17

   

3. Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: a systematic review and meta-analysis

   • Xiaojie Zheng
   • Fangbo Gao
   • Xingshun Qi

   OriginalPaper 19 November 2022 Pages: 18 - 31

   

4. Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients

   • Julie Wang
   • Hui Yin Lim
   • Prahlad Ho

   OriginalPaper Open access 31 July 2022 Pages: 32 - 41

   

5. Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention

   • Ioannis Lianos
   • Charalampos Varlamos
   • Dimitrios Alexopoulos

   OriginalPaper Open access 12 November 2022 Pages: 42 - 50

   

6. Targeted genetic analysis unveils novel associations between ACE I/D and APO T158C polymorphisms with D-dimer levels in severe COVID-19 patients with pulmonary embolism

   • Giuseppe Fiorentino
   • Giuditta Benincasa
   • Claudio Napoli

   OriginalPaper Open access 13 November 2022 Pages: 51 - 59

   

7. l-carnitine modulates free mitochondrial DNA DAMPs and platelet storage lesions during storage of platelet concentrates

   • Saeede Bagheri
   • Shahram Samiee
   • Mohammad Reza Deyhim

   OriginalPaper 15 November 2022 Pages: 60 - 66

   

8. Safety and efficacy of fibrinogen concentrate in aortic arch surgery involving moderate hypothermic circulatory arrest

   • XinLiang Guan
   • Lei Li
   • HongJia Zhang

   OriginalPaper 28 September 2022 Pages: 67 - 73

   

9. Four-factor prothrombin complex concentrate use for on-label versus off-label indications: a retrospective cohort study

   • Brian D. Adkins
   • Hila Shaim
   • Sean G. Yates

   OriginalPaper 14 June 2022 Pages: 74 - 82

10. Ischaemic events in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a systematic review and meta-analysis

    • Tiffany T. S. Ye
    • Qi Zhuang Siah
    • Ching-Hui Sia

    ReviewPaper 03 October 2022 Pages: 83 - 91

    

11. Net clinical benefit of DOACs vs. usual anticoagulation treatment in venous thromboembolism and active cancer: systematic review and meta-analysis

    • Helena Michalopoulou
    • Dimitris Polyzos
    • Emmanouil Vavouranakis

    ReviewPaper 28 October 2022 Pages: 92 - 101

    

12. Stable CAD patients show higher levels of platelet-borne TGF-β1 associated with a superior pro-inflammatory state than the pro-aggregatory status; Evidence highlighting the importance of platelet-derived TGF-β1 in atherosclerosis

    • Javad Ahmadi
    • Ehteramolsadat Hosseini
    • Mehran Ghasemzadeh

    OriginalPaper 09 November 2022 Pages: 102 - 115

    

13. Empagliflozin activates JAK2/STAT3 signaling and protects cardiomyocytes from hypoxia/reoxygenation injury under high glucose conditions

    • Fan Zhang
    • Xudong Cao
    • Xiaolin Chen

    OriginalPaper 17 November 2022 Pages: 116 - 125

    

14. A multicentre observational study of the prevalence, management, and outcomes of subsegmental pulmonary embolism

    • Michael N Armitage
    • Aishah Z Mughal
    • Michael Newnham

    OriginalPaper Open access 07 November 2022 Pages: 126 - 133

    

15. Time from blood draw to multiple electrode aggregometry and association with platelet reactivity

    • David Hesselbarth
    • Diona Gjermeni
    • Christoph B. Olivier

    OriginalPaper Open access 08 November 2022 Pages: 134 - 140

    

16. Higher OAK (Oral Anticoagulation Knowledge) score at baseline associated with better TTR (Time in Therapeutic Range) in patients taking warfarin

    • Delaney Feldeisen
    • Constantina Alexandris-Souphis
    • Eva Kline-Rogers

    OriginalPaper 03 November 2022 Pages: 141 - 148

17. Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage

    • Camille Troyer
    • Wesley Nguyen
    • Dexter Wimer

    OriginalPaper Open access 10 November 2022 Pages: 149 - 155

    

18. Temporal trend in venous thromboembolism hospitalization rates in Brazilian older adults, 2010–2020

    • Milara Barp
    • Viviane Santos Mendes Carneiro
    • Valéria Pagotto

    OriginalPaper 06 November 2022 Pages: 156 - 165

    

19. Impact of clinical profile at admission on the outcomes in patients hospitalized for acute pulmonary embolism: data from the IPER Registry

    • Marco Zuin
    • Claudio Bilato
    • Loris Roncon

    OriginalPaper 09 November 2022 Pages: 166 - 174

    

20. Use of SAMe-TT₂R₂ in a racially diverse anticoagulation clinic: prediction of optimal anticoagulation

    • Kunkun Wang
    • Yun Lu
    • Richard W Asinger

    OriginalPaper 09 November 2022 Pages: 175 - 180

    

21. TAVR: nemesis of NOACs?

    • Amin Polzin
    • Carolin Helten
    • Tobias Zeus

    Report Open access 01 November 2022 Pages: 181 - 184

22. Antiplatelet therapy indication in patients also prescribed direct oral anticoagulants

    • Anisa Amirtabar
    • Sara R. Vazquez
    • Daniel M. Witt

    BriefCommunication 20 April 2022 Pages: 185 - 188

23. Association between thromboembolic events and COVID-19 infection within 30 days: a case–control study among a large sample of adult hospitalized patients in the United States, March 2020–June 2021

    • Ya-Lin A. Huang
    • Hussain Yusuf
    • Aaron M. Harris

    BriefCommunication 14 December 2022 Pages: 189 - 194

24. Correction to: The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTOR^TM2 trial to a real-world study: a head-to-head comparison

    • Samantha Pasca
    • PierGiorgio Cojutti
    • for the Italian rFXIII Study Group

    Correction 01 December 2022 Pages: 195 - 195